TrialThe Journal of clinical investigation2015
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
Mark R Rigby et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
181 papers cite itlatest 60 shown
this paperpooled ittrialcites it